MAGENT

Hematology · LIVE

Perioperative DOAC interruption

Perioperative DOAC

Return published elective perioperative DOAC hold and resume day counts from Douketis 2022 (PAUSE-style implementation considerations, recommendations 22-25) given the INN, procedure bleed-risk category, and dabigatran CrCl when required.

LIVE $0.005 USDC GET /api/calc/periop_doac

Markdown: /docs/periop-doac.md · Canonical: https://magentlab.com/docs/periop-doac

Not a medical device. Not a diagnosis, dose, or listing recommendation.

What it computes

Return published elective perioperative DOAC hold and resume day counts from Douketis 2022 (PAUSE-style implementation considerations, recommendations 22-25) given the INN, procedure bleed-risk category, and dabigatran CrCl when required.

When to use

When an agent needs the Douketis 2022 elective DOAC interruption table for apixaban, rivaroxaban, edoxaban, or dabigatran and must not apply a warfarin 5-day hold, heparin bridging, or an urgent-surgery pathway.

When not to use

  • Not a medical device. Not a prescription and not an anticoagulation order. A licensed clinician remains responsible for timing around an elective procedure.
  • Elective surgery or procedure only. Not urgent or emergency surgery. Not a warfarin or VKA 5-day interruption.
  • Recommendation 26 suggests against heparin bridging of a DOAC. heparin_bridge is always false. magent does not order heparin.
  • magent does not assay CrCl. The caller assigns CrCl for dabigatran. CrCl must be absent for apixaban, rivaroxaban, and edoxaban.
  • INN names only (apixaban, rivaroxaban, edoxaban, dabigatran). Not a diagnosis of bleed risk; the caller assigns low_to_moderate or high.

Formula

Douketis 2022 PAUSE-style elective DOAC interruption (recommendations 22-25): apixaban/rivaroxaban/edoxaban hold 1 day (low_to_moderate) or 2 days (high); dabigatran CrCl>=50 same 1/2; dabigatran CrCl<50 hold 2 (low_to_moderate) or 4 (high); resume 1 day after low_to_moderate or 2 days after high; heparin_bridge always false (recommendation 26)

Citation

Title
Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline
Authors
Douketis JD, Spyropoulos AC, Murad MH, et al.
Source
Chest. 2022;162(5):e207-e243
DOI
10.1016/j.chest.2022.07.025

Worked example

Apixaban, low-to-moderate bleed risk

Given: bleed_risk=low_to_moderatedoac=apixaban

  1. doac is apixaban (factor Xa inhibitor); CrCl is not used
  2. bleed_risk is low_to_moderate → hold 1 day before and resume 1 day after
  3. heparin_bridge is false (recommendation 26)

Dabigatran, high bleed risk, CrCl 40

Given: bleed_risk=highcrcl_ml_min=40doac=dabigatran

  1. doac is dabigatran and caller-assigned CrCl 40 is < 50
  2. bleed_risk is high → hold 4 days before and resume 2 days after
  3. heparin_bridge is false (recommendation 26)

Also searched as

  • perioperative DOAC
  • DOAC interruption
  • PAUSE DOAC
  • Douketis perioperative
  • elective DOAC hold
  • dabigatran CrCl hold
  • ACCP antithrombotic
  • perioperative apixaban

Try

Opens the live endpoint. Unpaid browser requests show the paywall; agents should send Accept: application/json.

/api/calc/periop_doac?doac=apixaban&bleed_risk=low_to_moderate

Full URL: https://api.magentlab.com/api/calc/periop_doac?doac=apixaban&bleed_risk=low_to_moderate

Call

Expect HTTP 402 until you retry with PAYMENT-SIGNATURE. Incomplete query params return HTTP 400 before any quote or charge.

curl -i -H "Accept: application/json" "https://api.magentlab.com/api/calc/periop_doac?doac=apixaban&bleed_risk=low_to_moderate"

Parameters

Name Type Required Description
doac string required · apixaban, rivaroxaban, edoxaban, dabigatran Direct oral anticoagulant INN, case-insensitive: apixaban, rivaroxaban, edoxaban, or dabigatran. Elective procedures only. Not warfarin or a VKA.
bleed_risk string required · low_to_moderate, high Procedure bleed-risk category from Douketis 2022, case-insensitive: low_to_moderate or high. Caller assigns the category. Not urgent surgery.
crcl_ml_min number optional Caller-assigned creatinine clearance in mL/min (15-120). Required only when doac is dabigatran. Must be absent for apixaban, rivaroxaban, and edoxaban. magent does not assay CrCl.

Bulk (POST)

POST the same path with a JSON items array. The first item is the GET unit; each additional item is $0.002. Invalid items return HTTP 400 before settlement.

POST /api/calc/periop_doac Max 25 unit_amount + extra_item_amount * (n - 1) extra $0.002 PREVIEW

  • 1 to 25 items. Each item uses the same keys as the GET query parameters.
  • POST of 1 item costs the same as GET. Lists longer than 25: chunk into multiple POSTs. Extra items still execute; do not pad dummy rows.
  • The first invalid item fails the whole request (index in the 400 JSON). You are not charged.
  • HTTP 200 is {count, path, items}. Each items[i] is the GET 200 body for that row.
  • Catalog misses (empty matches, found=false) stay paid 200s inside that slot.
  • x402 resource URL is this path plus n and body_sha256. Browsers that prefer text/html get the same paywall as GET; Pay retries POST with the same items.

Example request (fixture)

{
  "items": [
    {
      "bleed_risk": "low_to_moderate",
      "doac": "apixaban"
    },
    {
      "bleed_risk": "low_to_moderate",
      "doac": "apixaban"
    }
  ]
}

Open bulk paywall →

Opens a two-item fixture on the API host. Unpaid browsers get the same MetaMask paywall as GET; Pay retries POST with those items.

Example 200 (fixture)

{
  "count": 2,
  "path": "/api/calc/periop_doac",
  "items": [
    {
      "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
      "citation": {
        "authors": "Douketis JD, Spyropoulos AC, Murad MH, et al.",
        "doi": "10.1016/j.chest.2022.07.025",
        "id": "douketis-2022",
        "pmid": "35964704",
        "source": "Chest. 2022;162(5):e207-e243",
        "title": "Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline"
      },
      "formula": "periop_doac",
      "formula_expression": "Douketis 2022 PAUSE-style elective DOAC interruption (recommendations 22-25): apixaban/rivaroxaban/edoxaban hold 1 day (low_to_moderate) or 2 days (high); dabigatran CrCl>=50 same 1/2; dabigatran CrCl<50 hold 2 (low_to_moderate) or 4 (high); resume 1 day after low_to_moderate or 2 days after high; heparin_bridge always false (recommendation 26)",
      "criteria": [
        {
          "value": "apixaban",
          "factor": "doac",
          "met": true
        },
        {
          "value": "low_to_moderate",
          "factor": "high_bleed_risk",
          "met": false
        },
        {
          "factor": "dabigatran",
          "met": false
        },
        {
          "factor": "dabigatran_crcl_lt_50",
          "met": false
        }
      ],
      "bleed_risk": "low_to_moderate",
      "doac": "apixaban",
      "heparin_bridge": false,
      "hold_days_before": 1,
      "resume_days_after": 1,
      "total_pre_post_days": 2
    },
    {
      "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
      "citation": {
        "authors": "Douketis JD, Spyropoulos AC, Murad MH, et al.",
        "doi": "10.1016/j.chest.2022.07.025",
        "id": "douketis-2022",
        "pmid": "35964704",
        "source": "Chest. 2022;162(5):e207-e243",
        "title": "Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline"
      },
      "formula": "periop_doac",
      "formula_expression": "Douketis 2022 PAUSE-style elective DOAC interruption (recommendations 22-25): apixaban/rivaroxaban/edoxaban hold 1 day (low_to_moderate) or 2 days (high); dabigatran CrCl>=50 same 1/2; dabigatran CrCl<50 hold 2 (low_to_moderate) or 4 (high); resume 1 day after low_to_moderate or 2 days after high; heparin_bridge always false (recommendation 26)",
      "criteria": [
        {
          "value": "apixaban",
          "factor": "doac",
          "met": true
        },
        {
          "value": "low_to_moderate",
          "factor": "high_bleed_risk",
          "met": false
        },
        {
          "factor": "dabigatran",
          "met": false
        },
        {
          "factor": "dabigatran_crcl_lt_50",
          "met": false
        }
      ],
      "bleed_risk": "low_to_moderate",
      "doac": "apixaban",
      "heparin_bridge": false,
      "hold_days_before": 1,
      "resume_days_after": 1,
      "total_pre_post_days": 2
    }
  ]
}

Response

Field Type Description
formula string periop_doac
formula_expression string Douketis 2022 PAUSE-style elective hold and resume tree
doac string Normalized INN: apixaban, rivaroxaban, edoxaban, or dabigatran
bleed_risk string Normalized bleed-risk category: low_to_moderate or high
crcl_ml_min number Caller-assigned CrCl in mL/min used for dabigatran. Omitted when doac is not dabigatran.
hold_days_before integer Days to hold the DOAC before an elective procedure
resume_days_after integer Days after the procedure before resuming the DOAC
heparin_bridge boolean Always false. Recommendation 26 suggests against heparin bridging of a DOAC.
total_pre_post_days integer hold_days_before plus resume_days_after
criteria array Tree rows for doac, high_bleed_risk, dabigatran, and dabigatran_crcl_lt_50
citation object Douketis 2022 Chest citation
disclaimer string Not-a-device notice

Example JSON

Machine form of the same example. Frozen fixture. Not a live lookup.

{
  "disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
  "citation": {
    "authors": "Douketis JD, Spyropoulos AC, Murad MH, et al.",
    "doi": "10.1016/j.chest.2022.07.025",
    "id": "douketis-2022",
    "pmid": "35964704",
    "source": "Chest. 2022;162(5):e207-e243",
    "title": "Perioperative Management of Antithrombotic Therapy: An American College of Chest Physicians Clinical Practice Guideline"
  },
  "formula": "periop_doac",
  "formula_expression": "Douketis 2022 PAUSE-style elective DOAC interruption (recommendations 22-25): apixaban/rivaroxaban/edoxaban hold 1 day (low_to_moderate) or 2 days (high); dabigatran CrCl>=50 same 1/2; dabigatran CrCl<50 hold 2 (low_to_moderate) or 4 (high); resume 1 day after low_to_moderate or 2 days after high; heparin_bridge always false (recommendation 26)",
  "criteria": [
    {
      "value": "apixaban",
      "factor": "doac",
      "met": true
    },
    {
      "value": "low_to_moderate",
      "factor": "high_bleed_risk",
      "met": false
    },
    {
      "factor": "dabigatran",
      "met": false
    },
    {
      "factor": "dabigatran_crcl_lt_50",
      "met": false
    }
  ],
  "bleed_risk": "low_to_moderate",
  "doac": "apixaban",
  "heparin_bridge": false,
  "hold_days_before": 1,
  "resume_days_after": 1,
  "total_pre_post_days": 2
}

Client errors (HTTP 400)

Invalid params return 400 without charge. Shared HTTP 402 and 503 meanings: Payments.

HTTP Code When
400 invalid_periop_doac Perioperative DOAC hold inputs must match Douketis 2022 drug, bleed-risk category, and dabigatran CrCl window from that guideline. Returned before settlement; you are not charged.
400 invalid_items POST body must be a JSON object with only an items array Returned before settlement; you are not charged.
400 invalid_item_count items must be an array of 1 to 25 objects Returned before settlement; you are not charged.
400 invalid_item each items entry must be a JSON object Returned before settlement; you are not charged.

Related tools

  • DOAC Score — Compute the Aggarwal 2023 DOAC Score from age, CrCl or eGFR, and caller-assigned Table 2 flags for patients with atrial fibrillation on a DOAC.
  • HAS-BLED — Compute the HAS-BLED bleeding-risk score from discrete clinical flags.

Payment

Unpaid requests return HTTP 402 even if query parameters or POST items are missing or invalid, so CDP and agents can index the path. After a PAYMENT-SIGNATURE, invalid params return HTTP 400 JSON before settlement. magent does not charge. Fix the params, then request a new 402 quote for that complete URL. Catalog misses (empty matches, found=false) are valid paid 200s. Unpaid valid requests return HTTP 402 with a base64 PAYMENT-REQUIRED header. HTTP 503 is not a new quote: retry the same PAYMENT-SIGNATURE. Full handshake and shared payment errors: Payments. Stdio MCP: /docs/mcp.

Guarantees

  • HTTP 402 is unpaid, including a missing query. After PAYMENT-SIGNATURE, invalid parameters return HTTP 400 before settlement. You are not charged. HTTP 402 never includes the tool JSON.
  • exact: settlement finishes before the tool (paymentFlow upfront). batch-settlement: verify/deposit before the tool; chargedCumulativeAmount commits after HTTP 2xx. Uncertain or failed settlement fails closed (HTTP 503). Retry the same PAYMENT-SIGNATURE.
  • HTTP 402 is unpaid only. Do not sign a second authorization because of a 503.
  • Execution is timeout-bounded and concurrency-capped.
  • Calculator inputs are stored encrypted for allowlisted operators (Magent Console). They are not in public logs, SSH lookups, catalog, or rollups. Request logs store path without query.